as 12-20-2024 4:00pm EST
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded: | 1952 | Country: | United States |
Employees: | N/A | City: | HERCULES |
Market Cap: | 9.1B | IPO Year: | N/A |
Target Price: | $414.00 | AVG Volume (30 days): | 203.8K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -27.41 | EPS Growth: | N/A |
52 Week Low/High: | $262.12 - $387.99 | Next Earning Date: | 02-13-2025 |
Revenue: | $2,580,209,000 | Revenue Growth: | -5.15% |
Revenue Growth (this year): | -2.48% | Revenue Growth (next year): | 2.92% |
BIO Breaking Stock News: Dive into BIO Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
Argus Research
11 days ago
MT Newswires
13 days ago
Argus Research
18 days ago
Zacks
23 days ago
Simply Wall St.
23 days ago
Insider Monkey
a month ago
Business Wire
a month ago
The information presented on this page, "BIO Bio-Rad Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.